The Therapeutic Goods Administration (TGA) has invited comments from interested persons or organisations on this consultation regulatory impact statement (Consultation RIS) before 5pm, 12 July 2013.
About the consultation
The purpose of this Consultation RIS is to seek public comment to help inform the Australian Government in decision making on proposed regulatory reforms to improve the management of public health risks in relation to the advertising of therapeutic goods to the general public.
This Consultation RIS:
- describes the existing regulatory framework
- documents problems associated with the existing regulatory framework
- outlines the objectives for reform
- suggests proposals for reform
- invites comments on likely impacts of implementation of the suggested proposals.
After consideration of public comment on this Consultation RIS, the TGA intends to prepare a final RIS to assist Government consideration of the next steps.
Comments are sought on
- how your interests may be affected by the proposals outlined in this paper
- the likely regulatory impacts and costs of the proposals on consumers and businesses
- matters relevant to the implementation of the proposals.
Document released for consultation on Friday 31 May 2013.
Interested parties should respond before 5pm, Friday 12 July 2013.
Feedback will be released following consideration of submissions.
Ken Harvey from MedReach will believe change when he sees it:
It’s hard to take TGA “reform” seriously when progress is so slow. Concerns (and recommendations) about advertising reform date back to the 2003 report of the “Expert Committee on Complementary Medicines in the Health System”.